跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Leflunomide Tablets
Approved
化学药品
Leflunomide Tablets
Emcure Pharmaceuticals Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Jul 30, 2024
Approval ID
8btvUMc5l8W
Company
Emcure Pharmaceuticals Ltd.
Type
化学药品
Approval Details
Approval Id
8btvUMc5l8W
Approval Number
国药准字HJ20240075
Generic Name
来氟米特片
Generic Name En
Leflunomide Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
20mg
Reg Date
2024-07-30
Expired Date
2029-07-29
Company Name
Emcure Pharmaceuticals Ltd.
Production Company Name
Emcure Pharmaceuticals Ltd.
Company Detail Path
/organization/emcure-pharmaceuticals-ltd
Production Company Detail Path
/organization/emcure-pharmaceuticals-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 30, 2024
Approval ID
8btvUMc5l8W
Type
化学药品
Back to NMPA Approvals
来氟米特片 - NMPA Drug Approval Details